Published in Psychol Med on April 01, 2009
Differences in Alzheimer disease clinical trial outcomes based on age of the participants. Neurology (2015) 1.45
The diagnosis of young-onset dementia. Lancet Neurol (2010) 1.37
The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol (2012) 1.18
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. Eur J Nucl Med Mol Imaging (2012) 1.10
APOEε2 is associated with milder clinical and pathological Alzheimer disease. Ann Neurol (2015) 0.94
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Alzheimers Dement (2014) 0.89
Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response. BMC Geriatr (2013) 0.85
Alzheimer disease: hippocampal volume loss and Alzheimer disease progression. Nat Rev Neurol (2009) 0.81
Exercise and early-onset Alzheimer's disease: theoretical considerations. Dement Geriatr Cogn Dis Extra (2012) 0.79
Effects of epsilon4 on object recognition in the non-demented elderly. Curr Aging Sci (2010) 0.77
Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2015) 0.75
Exploring Biomarkers for Alzheimer's Disease. J Clin Diagn Res (2016) 0.75
The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up. J Alzheimers Dis (2017) 0.75
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers. J Alzheimers Dis (2017) 0.75
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev (2008) 8.42
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia (2006) 4.71
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain (2008) 3.36
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry (2002) 2.41
Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 2.29
EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol (2010) 2.21
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology (1998) 2.17
Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry (2000) 1.97
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging (2006) 1.91
Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol (2000) 1.89
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology (2009) 1.88
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain (2008) 1.84
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis (2005) 1.80
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett (2000) 1.77
Familial aggregation in frontotemporal dementia. Neurology (1998) 1.76
The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry (2004) 1.73
The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology (2006) 1.71
Health-related quality of life in the first year following diagnosis of Type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabet Med (2004) 1.70
[Acute subdural hematoma following minor head injury]. Ned Tijdschr Geneeskd (1992) 1.69
Hippocampal atrophy in Alzheimer disease: age matters. Neurology (2006) 1.66
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia (2006) 1.66
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Comparison of two different approaches for the analysis of data from a prospective cohort study: an application to work related risk factors for low back pain. Occup Environ Med (2002) 1.64
Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease. Neuroimage (2006) 1.64
Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology (2001) 1.59
Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study. J Affect Disord (2002) 1.58
Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology (2007) 1.57
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology (2011) 1.56
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis (2006) 1.56
Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways. Hippocampus (2000) 1.55
Functional MR imaging in Alzheimer's disease during memory encoding. AJNR Am J Neuroradiol (2001) 1.54
Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry (1996) 1.54
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.53
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain (1998) 1.52
Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol (2008) 1.50
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology (2004) 1.46
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology (2007) 1.46
FMRI of visual encoding: reproducibility of activation. Hum Brain Mapp (2000) 1.46
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry (1999) 1.45
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage (2002) 1.44
Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet (2001) 1.43
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology (2007) 1.43
A case of macrocephaly, hydrocephalus, megacerebellum, white matter abnormalities and Rosenthal fibres. Dev Med Child Neurol (1993) 1.41
Meningeal Gd-DTPA enhancement in multiple sclerosis. AJNR Am J Neuroradiol (1992) 1.40
Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord (1998) 1.40
[Doubts regarding the existence and clinical relevance of 'new' risk determinants of cardiovascular disease are unfounded]. Ned Tijdschr Geneeskd (2008) 1.39
A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry (2009) 1.39
[The immune system and Alzheimer's disease]. Tijdschr Psychiatr (2011) 1.38
Behavioral symptoms in mild cognitive impairment. Neurology (2004) 1.36
Hippocampal shape analysis in Alzheimer's disease: a population-based study. Neuroimage (2007) 1.35
Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol (1996) 1.35
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology (2007) 1.33
Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J (2009) 1.32
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology (2009) 1.30
Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol (1998) 1.30
EEG synchronization in mild cognitive impairment and Alzheimer's disease. Acta Neurol Scand (2003) 1.27
Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (2001) 1.26
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord (2004) 1.22
Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology (2010) 1.22
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? J Neurol Neurosurg Psychiatry (2005) 1.21
Within-subject reproducibility of visual activation patterns with functional magnetic resonance imaging using multislice echo planar imaging. Magn Reson Imaging (1998) 1.21
Normal fetal lung volume measured with three-dimensional ultrasound. Ultrasound Obstet Gynecol (2006) 1.21
No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study. Diabet Med (2004) 1.20
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol (2012) 1.19